Navigation Links
US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness
Date:9/19/2007

NEW YORK, Sept. 19 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pafuramidine (DB289) for treating Human African Trypanosomiasis (HAT), also known as African sleeping sickness. Orphan drug designation provides Immtech with numerous financial and regulatory benefits during pafuramidine's development, including government grants for conducting clinical trials, waiver of New Drug Application submission fees, tax credits, and a seven-year market exclusivity upon final FDA approval.

Pafuramidine is currently in phase III clinical trials for African sleeping sickness at six trial sites in Africa. The infectious disease, spread by tsetse flies, threatens approximately 60 million people in over 30 countries in sub-Saharan Africa. Current treatments for the disease are associated with high levels of toxicity and are difficult to administer. Safety data for pafuramidine has been positive to date, and the FDA and Ethics Committees responsible for the study oversight currently allow adolescents, pregnant women and nursing mothers to participate in these clinical trials. These groups are particularly vulnerable to the disease.

"The FDA's decision reflects the significant need for new treatments for African sleeping sickness," stated Carol Olson, MD, PhD, Immtech's Sr. Vice President and Chief Medical Officer. "Pafuramidine has the potential to be the first oral treatment for this fatal and neglected disease. Patients often put off screening and treatment because current drugs must be given by injection. A safe and effective pill that is readily available should facilitate cure for more patients i
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
5. Point of Care Strep Tests Speed Treatment, Lower Costs
6. Rapid HIV Testing Increases Possibility of Treatment
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
(Date:7/30/2014)... FOREST, Ill., July 30, 2014  Hospira, Inc. ... provider of injectable drugs and infusion technologies, today ... 30, 2014. Net sales for the quarter were ... were $0.72. (Adjusted* measures exclude specified items as ... attached schedules.) On a U.S. Generally Accepted Accounting ...
(Date:7/30/2014)... VILLAGE, Nev. , July 30, 2014  PDL ... announced that company management will participate in the Jefferies ... Boston , Massachusetts. The conference will occur on August ... About PDL BioPharma, Inc. PDL BioPharma manages ... of its Queen et al. antibody humanization patents and ...
Breaking Medicine Technology:PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced that it expects revenue for the fourth ... Revenues for the full year were approximately $55 million, ... increase of approximately 10% in revenues from the core ...
... Nalco (NYSE: NLC ), providing essential ... Water and Process Services division is implementing a price ... or as contracts permit.  Pricing for most Nalco programs ... product mix. Price increases will vary by country and ...
Cached Medicine Technology:STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4Nalco Announces Price Increase 2Nalco Announces Price Increase 3
(Date:7/30/2014)... July 30, 2014 Ticket Down ... at Metlife Stadium in East Rutherford, NJ. Fresh off ... look to get back to their winning ways in international ... MetLife Stadium in East Rutherford, N.J. These two South American ... and will continue their feud when they invade the Northeast ...
(Date:7/30/2014)... A study of high school students by University of ... links between insomnia-related mental health conditions among teens. , ... surveyed more than 300 Australian high school students aged ... condition and the time of day they were most ... published in the journal Sleep Medicine ...
(Date:7/30/2014)... Victory Medical Center Craig Ranch , a ... of a pediatric unit focused on: orthopedics, ear, nose, ... in the pediatrics departments are all specially trained to ... Timothy Cole, Dr. Dale Ehmer, Dr. Barry Humeniuk, Dr. ... Dr. Nicholas Peiffer lead the pediatrics team. Victory Medical ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Building ENT ... throat, allergy, and audiology practice in Westchester County takes ... state-of-the-art technology, a superb underlying corporate structure and protocols, ... It also takes a leading Chief Financial Officer to ... Journal (WCBJ), that’s exactly what it possesses. In fact, ...
(Date:7/30/2014)... (HealthDay News) -- A simple blood test could help ... research finds. The test would measure the concentration ... women,s red blood cells. The findings from this study -- ... doctors predict the risk of serious birth defects known as ... development of a growing fetus. In addition to naturally ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at MetLife Stadium 2Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at MetLife Stadium 3Health News:Teen insomnia is linked with depression and anxiety 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3Health News:Blood Test Might Help Prevent Certain Birth Defects 2
... IRVINE, Calif. , March 11 Renowned pediatrician, author, and lecturer Dr. William Sears ... of children,s supplements and healthy snacks at the Natural Products Expo West convention to be held in ... help nourish young bodies and minds." , ... ...
... ... security has wide-ranging benefits compared to its costs in the fight against poverty-related problems, ... on global hunger. He cites findings from Nobel laureates and a Lancet medical journal ... ...
... ... CareLogic™ user community. , ... Nashville, Tenn. (Vocus) March 11, 2010 -- Qualifacts Systems Inc. , the ... management systems to behavioral health and human services providers, has added New Directions Inc. ...
... ... President of International Orion Health – Charles Scatchard. Orion Health celebrates “phenomenal success” with ... , ... (PRWEB) March 12, 2010 -- To further the ongoing success with implementing Healthcare IT ...
... for Tap Water at Participating Restaurants or Via Tapproject.org During World Water Week ( March 21-27, 2010 ) , ... , , ... ... as Campaign Spokesperson , ...
... than smoking pot, snorting cocaine among 12-year-olds, study finds ... have used inhalants to get high than marijuana, ... , These potentially deadly inhalants include aerosol computer cleaners, ... or sniffed and can cause addiction or sudden death ...
Cached Medicine News:Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 2Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 3Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 2Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 3Health News:Qualifacts is Behavioral Health SaaS Provider of Choice in Connecticut 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 3Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 4Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 5Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 2Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 3Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 4Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 5Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 6Health News:Inhalant Abuse a Deadly Middle-School Concern 2
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
... is ALOKAs answer to the ... Super High Density, versatile convex ... offering 5 levels of fundamental ... settings of Harmonic frequencies. This ...
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: